[68Ga]Ga-PentixaFor in Primary Aldosteronism: Billion-Dollar Potential in an Underserved Mass Market
![[68Ga]Ga-PentixaFor in Primary Aldosteronism: Billion-Dollar Potential in an Underserved Mass Market](https://images.unsplash.com/photo-1488459716781-31db52582fe9?auto=format&fit=crop&w=1600&q=70)
Pentixapharm Holding AG today announced the positive feedback from the FDA ("study may proceed") for the initiation of the Phase III PANDA study with [68Ga]Ga-PentixaFor. Subject to successful development and regulatory approval, the company sees an annual revenue potential of over one...
Pentixapharm Holding AG today announced the positive feedback from the FDA ("study may proceed") for the initiation of the Phase III PANDA study with [68Ga]Ga-PentixaFor. Subject to successful development and regulatory approval, the company sees an annual revenue potential of over one...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.